| 1 (23) | Google Inc, USA | USA |  |
| 2 (24) | Google International LLC | MUL | |
| 3 (74) | Samsung Corp * | MUL | |
| 4 (91) | F Hoffmann-La Roche * | MUL | |
| 5 (94) | Microsoft Corp * | MUL | |
| 6 (108) | Novartis Institutes for Biomedical Research, United States | USA | |
| 7 (110) | Hoffmann-La Roche Ltd, United States | USA | |
| 8 (112) | Regeneron Pharmaceuticals Inc | USA | |
| 9 (116) | Genentech Inc | USA | |
| 10 (134) | State Grid Corporation of China * | CHN | |
| 11 (139) | Hoffmann-La Roche, GmbH., Germany | DEU | |
| 12 (143) | Novartis Institutes for Biomedical Research, Switzerland | CHE | |
| 13 (144) | Foundation Medicine Inc | USA | |
| 14 (149) | AstraZeneca * | MUL | |
| 15 (155) | Alphabet Inc * | MUL | |
| 16 (157) | Bristol-Myers Squibb Company, United States | USA | |
| 17 (168) | Bristol-Myers Squibb Company * | MUL | |
| 18 (171) | Toyota Group * | MUL | |
| 19 (182) | Johnson & Johnson * | MUL | |
| 20 (184) | Janssen Biotech Inc | USA | |
| 21 (188) | Biogen Idec, USA | USA | |
| 22 (190) | Janssen | MUL | |
| 23 (192) | Novartis * | MUL | |
| 24 (194) | Gilead Sciences Inc, United States | USA | |
| 25 (195) | Gilead Sciences * | MUL | |
| 26 (196) | Biogen Idec * | MUL | |
| 27 (200) | Sanofi, United States | USA | |
| 28 (202) | Merck * | MUL | |
| 29 (217) | Sanofi * | MUL | |
| 30 (227) | Philips Research, Eindhoven | NLD | |
| 30 (227) | Pfizer * | MUL | |
| 32 (228) | Hoffmann-La Roche Ltd, Switzerland | CHE | |
| 33 (229) | Merck KGaA, Germany | DEU | |
| 34 (230) | Pfizer Inc, United States | USA | |
| 35 (232) | VTT Technical Research Centre of Finland | FIN | |
| 35 (232) | AstraZeneca, United Kingdom | GBR | |
| 37 (240) | Siemens * | MUL | |
| 38 (243) | Merck & Co Inc, United States | USA | |
| 39 (244) | GlaxoSmithKline * | MUL | |
| 40 (253) | IBM United States | USA | |
| 40 (253) | Eli Lilly and Company, United States | USA | |
| 42 (256) | GlaxoSmithKline, United States | USA | |
| 43 (265) | Amgen * | MUL | |
| 44 (267) | Eli Lilly * | MUL | |
| 45 (269) | Siemens AG, USA | USA | |
| 46 (272) | IBM Research * | MUL | |
| 47 (275) | Takeda Pharmaceutical Co Inc, Japan | JPN | |
| 48 (277) | Amgen, USA | USA | |
| 49 (280) | AstraZeneca, United States | USA | |
| 50 (283) | Novo Nordisk * | MUL | |
| 51 (286) | Novo Nordisk A/S | DNK | |
| 52 (293) | Celgene Corp | USA | |
| 53 (294) | AbbVie * | MUL | |
| 54 (295) | AbbVie Inc, United States | USA | |
| 55 (300) | Bayer * | MUL | |
| 56 (301) | Siemens AG, Germany | DEU | |
| 57 (304) | Koninklijke Philips NV * | MUL | |
| 58 (307) | Boehringer Ingelheim * | MUL | |
| 58 (307) | Danone Nederland BV | NLD | |
| 60 (308) | Siemens Healthineers, USA | USA | |
| 61 (310) | Takeda Pharmaceuticals International Inc * | MUL | |
| 62 (315) | Boehringer Ingelheim, USA | USA | |
| 63 (318) | Robert Bosch * | MUL | |
| 63 (318) | Takeda Pharmaceuticals International Inc, USA | USA | |
| 65 (321) | Danone * | MUL | |
| 66 (322) | Bayer AG, Germany | DEU | |
| 67 (335) | Janssen Research & Development, LLC | BEL | |
| 68 (349) | Boehringer Ingelheim GmbH Germany | DEU | |
| 69 (364) | Beijing Academy of Agriculture and Forestry Sciences | CHN | |
| 70 (369) | GlaxoSmithKline, United Kingdom | GBR | |
| 71 (371) | Novartis, Switzerland | CHE | |
| 72 (381) | UCB Pharma SA * | MUL | |
| 73 (390) | General Electric Company * | MUL | |
| 74 (397) | AstraZeneca, Sweden | SWE | |
| 75 (400) | Daiichi Sankyo Co., Ltd. Japan | JPN | |
| 76 (416) | Hitachi * | MUL | |
| 76 (416) | Nestle * | MUL | |
| 78 (448) | Shionogi & Co Ltd | JPN | |
| 79 (451) | Novartis Pharmaceuticals, United States | USA | |
| 80 (452) | UCB Pharma SA, Brussels | BEL | |
| 81 (458) | GlaxoSmithKline, Belgium | BEL | |
| 82 (470) | Translational Research Institute | AUS | |
| 83 (479) | Sanofi, Germany | DEU | |
| 84 (481) | Bayer Corp, USA | USA | |
| 85 (487) | Daiichi Sankyo Co., Ltd. * | MUL | |
| 86 (501) | BASF Group * | MUL | |
| 87 (502) | Astellas Pharma Inc | JPN | |
| 88 (520) | Pfizer Inc, United Kingdom | GBR | |
| 89 (526) | Allergan plc * | MUL | |
| 90 (537) | IMEC International | BEL | |
| 91 (539) | BASF, Germany | DEU | |
| 92 (543) | Procter & Gamble Co * | MUL | |
| 93 (544) | Procter & Gamble, USA | USA | |
| 94 (545) | Lockheed Martin Corp * | USA | |
| 95 (546) | Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique | FRA | |
| 96 (556) | DowDupont * | MUL | |
| 97 (558) | GE Healthcare | MUL | |
| 98 (563) | Springer Nature * | MUL | |
| 99 (568) | GeneDx | USA | |
| 100 (571) | Springer Nature, New Zealand | NZL | |
| 101 (576) | Johnson & Johnson, United States | USA | |
| 102 (579) | Aramco * | MUL | |
| 103 (583) | SINTEF Group | NOR | |
| 104 (587) | Medtronic * | MUL | |
| 105 (614) | RTI Health Solutions | USA | |
| 106 (618) | Manipal Global Education Group * | MUL | |
| 107 (627) | Nippon Telegraph and Telephone Corp, Japan | JPN | |
| 108 (630) | Nippon Telegraph and Telephone Corporation * | MUL | |
| 109 (641) | Abbott Laboratories * | MUL | |
| 110 (642) | Unilever * | MUL | |
| 111 (661) | EMMES Corp | USA | |
| 112 (666) | Saudi Arabian Oil Company | SAU | |
| 113 (680) | ARUP Laboratories | USA | |
| 114 (718) | Abu Dhabi Health Services Co * | ARE | |
| 115 (776) | GE Healthcare China Co Ltd | CHN | |
| 116 (847) | Estacio Participacoes SA * | BRA | |
|
